Unassociated Document
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date
of
Report (Date of earliest event reported) July
10, 2007
Interpharm
Holdings, Inc.
(Exact
name of Registrant as specified in charter)
Delaware
|
0-22710
|
13-3673965
|
(State
or other jurisdic-
|
(Commission
|
(IRS
Employer
|
tion
of incorporation)
|
File
Number)
|
Identification
No.)
|
75
Adams Avenue, Hauppauge, New
York
|
11788
|
(Address
of principal executive
offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (631)
952 0214
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors;
Appointment
of Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
July
10, 2007, the Interpharm Holdings, Inc.’s (the “Company”) Board of Directors
appointed Peter Giallorenzo as its Chief Operating Officer. Prior to the
appointment as Chief Operating Officer, Mr. Giallorenzo already served as the
Company’s Chief Financial Officer and was an Executive Vice President. He will
continue in those positions. Details of Mr. Giallorenzo’s background and
employment agreement are set forth in the Company’s Current Report on Form 8-K
filed with the SEC on February 15, 2007.
Raj
Sutaria, the Company’s previous Chief Operating Officer, will no longer serve in
that position, but will continue with the Company as an Executive Vice
President.
As
of
July 10, 2007, Bhupatlal K. Sutaria, no longer serves as the President of the
Company. The position of President has not been filled as of the date of this
Current Report.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
INTERPHARM
HOLDINGS, INC. |
|
|
|
July
13,
2007 |
By: |
/s/ Peter
Giallorenzo |
|
Peter
Giallorenzo |
|
Chief Financial Officer and
Chief Operating
Officer
|